Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Chemical Relative of DNA Devised for Use as Nanotechnology Building Block

By Biotechdaily staff writers
Posted on 20 May 2008
In the ever-growing field of nanotechnology, researchers are constantly looking for new building blocks to drive advances and discovery to levels much smaller than the most minuscule particle of dust.

At the Biodesign Institute at Arizona State University (ASU; Tempe, USA), researchers are using DNA to make intricate nanosized objects. More...
Working at this scale holds great potential for advancing medical and electronic applications. DNA is an ideal building block for nanotechnology because they self-assemble, locking together into shapes based on natural chemical rules of attraction. This is a major advantage for Biodesign researchers such as Dr. Hao Yan, who rely on the novel chemical and physical properties of DNA to make their complex nanostructures.

While scientists are studying the potential of DNA nanotechnology, Biodesign Institute colleague Dr. John Chaput is working to give researchers new materials to aid their designs. In an article published in the May 7, 2008, issue of the Journal of the American Chemical Society, Dr. Chaput and his research team have constructed the first self-assembled nanostructures composed completely of glycerol nucleic acid (GNA)--a synthetic analog of DNA.

"Everyone in DNA nanotechnology is essentially limited by what they can buy off the shelf,” said Dr. Chaput, who is also an ASU assistant professor in the department of chemistry and biochemistry. "We wanted to build synthetic molecules that assembled like DNA, but had additional properties not found in natural DNA.”

The DNA helix comprises three simple parts: a sugar and a phosphate molecule that form the backbone of the DNA ladder, and one of four nitrogenous bases that make up the rungs. The nitrogenous base pairing rules in the DNA chemical alphabet fold DNA into a variety of useful shapes for nanotechnology, given that adenine (A) can only form a zipper-like chemical bond with thymine (T) and guanine (G) only pair with cytosine (C).

In the case of GNA, the sugar is the only difference with DNA. The five-carbon sugar typically found in DNA, called deoxyribose, is substituted by glycerol, which contains three carbon atoms.

Dr. Chaput has had a long-standing interest in working with chemical building blocks used to make molecules such as proteins and nucleic acids that do not exist in nature. When it came time to synthesize the first self-assembled GNA nanostructures, Dr. Chaput had to go back to basics. "The idea behind the research was what to start with a simple DNA nanostructure that we could just mimic.”

The first self-assembled DNA nanostructure was constructed by Dr. Ned Seeman's lab at Columbia University (New York, NY, USA) in 1998. Dr. Chaput's team was not only able to duplicate these structures, but unique to GNA, discovered that they could make mirror image nanostructures.

In nature, many molecules important to life like DNA and proteins have evolved to exist only as right-handed. The GNA structures, unlike DNA, turned out to be ‘enantiomeric' molecules, which in chemical terms means both left- and right-handed.

"Making GNA is not tricky, it's just three steps, and with three carbon atoms, only one stereo center,” said Dr. Chaput. "It allows us to make these right- and left-handed biomolecules. People have actually made left-handed DNA, but it is a synthetic nightmare. To use it for DNA nanotechnology could never work. It's too high of a cost to make, so one could never get enough material.”

The ability to make mirror image structures creates new possibilities for making nanostructures. The investigators also found a number of physical and chemical properties that were unique to GNA, including having a higher tolerance to heat than DNA nanostructures. Now, with a new material in use, which Dr. Chaput called "unnatural nucleic acid nanostructures,' the group hopes to explore the limits on the topology and types of structure they can make.

"We think we can take this as a basic building block and begin to build more elaborate structures in 2D [two-dimensional] and see them in atomic force microscopy images,” said Dr. Chaput. "I think it will be interesting to see where it will all go. Researchers come up with all of these clever designs now.”


Related Links:
Biodesign Institute at Arizona State University

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.